Skip to content

Improving uptake of colorectal cancer screening among primary care attendees

Testing the efficacy of providing a point-of-care faecal occult blood test, written screening advice and physician endorsement to improve uptake of colorectal cancer screening among primary care attendees.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12616001299493
Enrollment
114
Registered
2016-09-15
Start date
2016-09-06
Completion date
2017-05-15
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to test a primary care intervention that is designed to improve uptake of bowel cancer screening among primary care patients. Who is it for? You may be eligible to join this study if you are aged 50 to 74 years, are presenting for a general practice appointment, and have been identified via a brief baseline assessment as being at average or slightly increased risk of bowel cancer. You will not be eligible if you have been screened for bowel cancer using a faecal occult blood test (FOBT) in the past two years or colonoscopy in the past five years. Study details Clinics will be randomly allocated by day to intervention or usual care, therefore participants will receive the intervention based on the day of the week they attend the practice. Participants in the intervention group will receive: 1) A faecal occult blood test kit 2) A feedback sheet containing screening recommendations for those at average risk of bowel cancer 3) General practitioner endorsement of the importance of faecal occult blood test screening. Participants in the usual care group will receive standard care, and then the feedback sheet once the study is completed. All participants will be asked to complete a telephone interview 6 weeks after their initial appointment. During the interview, participants will be asked whether they have completed a faecal occult blood test within the past 6 weeks and will be asked questions to assess their bowel cancer screening knowledge. It is hoped that this primary care intervention will be an effective way to increase the uptake of bowel cancer screening

Interventions

The intervention group will receive a one-off individual intervention delivered in the primary care clinic. The intervention will involve the following: In the waiting room, a research assistant will provide intervention participants with an envelope prior to their GP appointment. The envelope will contain: a) a faecal occult blood test kit with: instructions for completion; pathology request form, and: pre-paid postage to mail the kit for analysis. b) A feedback sheet containing screening reco

The intervention group will receive a one-off individual intervention delivered in the primary care clinic. The intervention will involve the following: In the waiting room, a research assistant will provide intervention participants with an envelope prior to their GP appointment. The envelope will contain: a) a faecal occult blood test kit with: instructions for completion; pathology request form, and: pre-paid postage to mail the kit for analysis. b) A feedback sheet containing screening recommendations for those at average risk of colorectal cancer (including recommended: age to commence screening; screening test; frequency of testing). The sheet will also include methods to obtain FOBT as well as what to do with the FOBT provided. The research assistant will deliver the survey and for eligible patients will complete the pathology form but will not provide any medical advice or endorse completion of the intervention. The general practitioner will endorse the FOBT during the patient’s appointment. The GP will reinforce the importance of completing the FOBT and recommend the patient complete the FOBT using a script provided by the research team during a pre-study training session.

Sponsors

University of Newcastle
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
50 Years to 74 Years
Healthy volunteers
Yes

Inclusion criteria

Eligibility criteria for trial inclusion: Patients aged 50-74 presenting for an appointment with the general practitioner and that are: 1) at average or slightly above average risk of colorectal cancer; 2) have had no faecal occult blood test within the last two years or a colonoscopy in the last five years, will be eligible for participation in the trial. Average risk will be assessed by four questions relating individual and familial history of colorectal cancer.

Exclusion criteria

1) Those with a history of CRC or inflammatory bowel disease. 2) Those at greater than average risk of colorectal cancer 3) Non-English speaking 4) Too unwell to complete survey 5) Unable to complete survey for other reasons

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 26, 2026